Growth Equity Opportunities Iv, Llc - Net Worth and Insider Trading
Growth Equity Opportunities Iv, Llc Net Worth
The estimated net worth of Growth Equity Opportunities Iv, Llc is at least $59 Million dollars as of 2024-11-13. Growth Equity Opportunities Iv, Llc is the 10% Owner of AVEO Pharmaceuticals Inc and owns about 3,952,958 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $59 Million. Growth Equity Opportunities Iv, Llc is the 10% Owner of Achaogen Inc and owns about 5,215,128 shares of Achaogen Inc (AKAOQ) stock worth over $130,378. Growth Equity Opportunities Iv, Llc is also the 10% Owner of ARCA biopharma Inc and owns about 0 shares of ARCA biopharma Inc (ABIO) stock worth over $0. Details can be seen in Growth Equity Opportunities Iv, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Growth Equity Opportunities Iv, Llc has not made any transactions after 2020-06-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Growth Equity Opportunities Iv, Llc
Growth Equity Opportunities Iv, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Growth Equity Opportunities Iv, Llc owns 4 companies in total, including AVEO Pharmaceuticals Inc (AVEO) , Cascadian Therapeutics Inc (CASC) , and ARCA biopharma Inc (ABIO) among others .
Insider Ownership Summary of Growth Equity Opportunities Iv, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 10 percent owner |
| CASC | Cascadian Therapeutics Inc | 2018-03-09 | 10 percent owner |
| ABIO | ARCA biopharma Inc | 2018-02-26 | 10 percent owner |
 | | 2016-12-19 | 10 percent owner |
Growth Equity Opportunities Iv, Llc Latest Holdings Summary
Growth Equity Opportunities Iv, Llc currently owns a total of 3 stocks. Among these stocks, Growth Equity Opportunities Iv, Llc owns 3,952,958 shares of AVEO Pharmaceuticals Inc (AVEO) as of June 19, 2020, with a value of $59 Million and a weighting of 99.78%. Growth Equity Opportunities Iv, Llc owns 5,215,128 shares of Achaogen Inc (AKAOQ) as of December 19, 2016, with a value of $130,378 and a weighting of 0.22%. Growth Equity Opportunities Iv, Llc also owns 0 shares of ARCA biopharma Inc (ABIO) as of February 26, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Growth Equity Opportunities Iv, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 3,952,958 | 15.00 | 59,294,370 |
| AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
| ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 25.50 | 0 |
Holding Weightings of Growth Equity Opportunities Iv, Llc
Growth Equity Opportunities Iv, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Growth Equity Opportunities Iv, Llc has made a total of 1 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in AVEO Pharmaceuticals Inc is the acquisition of 1,428,571 shares on June 19, 2020, which cost Growth Equity Opportunities Iv, Llc around $8 Million.
According to the SEC Form 4 filings, Growth Equity Opportunities Iv, Llc has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the acquisition of 500,000 shares on December 19, 2016, which cost Growth Equity Opportunities Iv, Llc around $7 Million.
According to the SEC Form 4 filings, Growth Equity Opportunities Iv, Llc has made a total of 0 transactions in ARCA biopharma Inc (ABIO) over the past 5 years. The most-recent trade in ARCA biopharma Inc is the sale of 6,760 shares on February 26, 2018, which brought Growth Equity Opportunities Iv, Llc around $730,104.
Insider Trading History of Growth Equity Opportunities Iv, Llc
- 1
Growth Equity Opportunities Iv, Llc Trading Performance
GuruFocus tracks the stock performance after each of Growth Equity Opportunities Iv, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Growth Equity Opportunities Iv, Llc is 3.29%. GuruFocus also compares Growth Equity Opportunities Iv, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Growth Equity Opportunities Iv, Llc within 3 months outperforms 8 times out of 17 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Growth Equity Opportunities Iv, Llc's insider trading performs compared to the benchmark.
Performance of Growth Equity Opportunities Iv, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.91 | | | | | |
| Relative Return to S&P 500(%) | 1.69 | | | | | |
Growth Equity Opportunities Iv, Llc Ownership Network
Ownership Network List of Growth Equity Opportunities Iv, Llc
Ownership Network Relation of Growth Equity Opportunities Iv, Llc
Growth Equity Opportunities Iv, Llc Owned Company Details
What does AVEO Pharmaceuticals Inc do?
Who are the key executives at AVEO Pharmaceuticals Inc?
Growth Equity Opportunities Iv, Llc is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .
AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AVEO Pharmaceuticals Inc Insider Transactions
Growth Equity Opportunities Iv, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Growth Equity Opportunities Iv, Llc. You might contact Growth Equity Opportunities Iv, Llc via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
